We are live on
!
Find out more
Atossa Therapeutics
ATOS
ATOS
14 hedge funds and large institutions have $471K invested in Atossa Therapeutics in 2019 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
0.03% more ownership
Funds ownership: 0.19% → 0.22% (+0.03%)
7% less funds holding
Funds holding: 15 → 14 (-1)
8% less capital invested
Capital invested by funds: $513K → $471K (-$42.1K)
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
Holders
14
Holders Change
-1
Holders Change %
-6.67%
% of All Funds
0.28%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
1
Reduced
–
Closed
4
Calls
$17K
Puts
–
Net Calls
+$17K
Net Calls Change
-$7K
Top Buyers
| 1 |
Renaissance Technologies
New York
|
+$41K |
| 2 |
VF
Virtu Financial
New York
|
+$23K |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$10K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$7.18K |
Top Sellers
| 1 |
JP Morgan Chase
New York
|
-$22K |
| 2 |
Victory Capital Management
San Antonio,
Texas
|
-$3K |